MIGUEL YANES DELGADO: Open Payments
NPI 1821466616 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 12 payments from 8 companies in 2025. Trend: 2023 $337 · 2024 $507 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Radius Health, Inc. | 1 | $26 |
| ABIOMED | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: Ozempic, FARXIGA, Tymlos, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, MOUNJARO, NEXLETOL.
Industry payments across FL — which companies pay providers there.
